SurvivorNet10h
Deeply Concerning 17% Rise in Cervical Cancer Revealed; Almost Entirely Preventable — What You Need To Know About The HPV Vaccine
Cervical cancer, which fashion designer Liz Lange fought, is rising among women adults, as per the 2024 AACR Cancer Progress Report.
FiercePharma10h
Ahead of adcomm, FDA challenges broad use of PD-1 drugs in stomach cancer patients
Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
MINNEAPOLIS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today ...
MedPage Today8h
Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says
"If patients with low or no PD-L1 expression are not expected to benefit based on the available data, then administering anti ...
Business Insider16h
Transgene to Report Major Clinical Data before the end of 2024 – Confirmed Financial Visibility until Q4 2025
In monotherapy, BT-001 induced tumor shrinkage in 2 of 6 injected lesions.In combination with KEYTRUDA® (pembrolizumab), partial responses were observed in 2 of 6 patients who failed previous ...